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Retrospective Chart Review of
Metastatic Solid Tumor Discharges to
Subacute Rehab
Sarah Svetec, Molly Hanson CRNP*, Brooke Worster MD

Introduction and Objective
• Background: regaining strength through subacute
rehabilitation (SAR) as a mechanism to return cancer
patients to therapy is poorly understood
• Rationale: provide realistic advice to patients when
cancer-directed therapy must be stopped
• Inquiry question: what are cancer patients able to
accomplish following referral to SAR?
• Hypothesis: majority of patients will not return to
cancer-directed therapy following SAR; high functional
status at discharge will be the best predictor of return

Methods
• Population: metastatic solid tumor patients discharged to
SAR (2018-2020)
• Partnership: Neu Center Research Team

• Collection methods: retrospective chart review
• Main predictors & outcomes:
• Primary outcome = patient return to anti-cancer therapy
• Main predictor = PT functional status score (AMPAC)

• Analysis: descriptive statistics of patient outcomes +
logistic regression of AMPAC score and return to therapy

Results
• Results are pending!
• Example results:
Only 31 of the 112 patients (28%) returned to cancerdirected therapy within 60 days of discharge to SAR.
Functional status score was positively associated with
return to cancer-directed therapy. The average survival for
patients was 36 days from original discharge and 40% of
patients were readmitted to the hospital within 30 days.

Conclusions
• Potential impact: guidance to patients during difficult
turning point in care

• Limitations: sample only includes SKCC patients, decision is
highly individual

• Next steps: receive data through EPIC extraction → run
analysis with statistician → assist in writing paper
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